Blood Component Therapy For Cancer
نویسندگان
چکیده
منابع مشابه
Blood component therapy in obstetrics.
Hemorrhage is the leading cause of intensive care unit admission and one of the leading causes of death in the obstetric population. This emphasizes the importance of a working knowledge of the indications for and complications associated with blood product replacement in obstetric practice. This article provides current information regarding preparation for and administration of blood products...
متن کاملStability Analysis of Mathematical Model of Virus Therapy for Cancer
In this paper, we have analyzed a mathematical model for the study of interaction between tumor cells and oncolytic viruses. The model is analyzed using stability theory of differential equations. We gain some conditions for global stability of trivial and interior equilibrium point.
متن کاملCognitive-Existential Group Therapy for Parents of Children with Cancer
Objectives:This study used a quasi-experimental method inthe pretest-posttest to evaluate the efficacy of cognitive-existential group therapy on hopefulness in parents of children with cancer. Methods:Thirty parents (24 to 54 years old) of children with cancer were divided randomly into experimental and control groups. Both groups were assessed with Miller Hope Scale (1988), as pre-test. The...
متن کاملSkin Reaction in Radiation Therapy for Breast Cancer
Introduction The first medical intervention for many breast cancer patients is breast conserving surgery (BCS) and/or modified radical mastectomy (MRM). Most of these patients undergo radiation therapy, following surgery. The most common side-effect of breast radiotherapy is skin damage. In the present study, the severity of acute skin changes and the underlying causes were investigated in pati...
متن کاملDesign and development of CAR-T cells for cancer therapy
Introduction: Today, treatment with CAR-T cells is accepted as an effective treatment for blood malignancies. CAR-T cells are autologous T cells that are engineered by gene transfer techniques to express a chimeric antigen receptor (CAR). Despite the promising results and the approval of six CAR-T cell products; these products have not yet been approved for solid tumors. In addition, the high c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: CA: A Cancer Journal for Clinicians
سال: 1977
ISSN: 0007-9235
DOI: 10.3322/canjclin.27.4.194